Apollo Hospitals board meeting set as Apollo Hospitals stock sits 13.49 percent below high

Published on 10/13/2026 at 10:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Apollo Hospitals stock was INR 7,846.50 on October 13, below INR 9,070.50. The board meets November 4, with revenue up 21.00 percent in the first quarter.

Apollo Hospitals has scheduled a board meeting for November 4, 2026.
Apollo Hospitals stock was INR 7,846.50 on October 13, 2026, against a 52-week high of INR 9,070.50.
First-quarter fiscal 2027 revenue rose 21.00 percent year on year to INR 70.44 billion.
Prabhudas Lilladher raised its target to INR 10,000 from INR 9,350 after the first-quarter update.

Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals stock was at INR 7,846.50 on the NSE on October 13, 2026, while the 52-week high stood at INR 9,070.50. Economic Times reported on October 12, 2026, that Apollo Hospitals had scheduled a board meeting for November 4, 2026, giving the stock a defined upcoming corporate date.

Three dated operating markers

On May 22, 2026, ICICI Securities valued Apollo Hospitals at INR 9,660 per share after fiscal 2026 results, according to DSIJ. The broker cited fiscal 2026 revenue growth of 18.00 percent and EBITDA margin expansion to 15.30 percent.

On August 14, 2026, Prabhudas Lilladher raised its target to INR 10,000 from INR 9,350, according to DSIJ. The latest dated event came on October 12, 2026, when Apollo Hospitals announced the November 4 board meeting.

First-quarter growth sets the benchmark

The first quarter of fiscal 2027 provides the clearest operating reference. Apollo Hospitals reported revenue of INR 70.44 billion, up 21.00 percent year on year, while EBITDA increased 28.00 percent to INR 10.92 billion, according to DSIJ.

Adjusted profit after tax rose 34.00 percent year on year to INR 5.81 billion. The hospital segment grew 22.00 percent year on year, while Apollo HealthCo revenue increased 20.00 percent to INR 29.77 billion, showing that the growth story extends beyond hospital operations.

What does the November date add?

The November 4 meeting gives investors the next formal checkpoint after the strong first-quarter figures. Management had guided for hospital revenue growth of 20.00 percent in fiscal 2027, comprising 13.00 to 14.00 percent growth from established hospitals and 7.00 percent from new units, according to DSIJ.

The valuation remains above the latest operating figures in absolute terms: the INR 10,000 target from Prabhudas Lilladher is 27.43 percent above the INR 7,846.50 NSE price. That gap reflects the broker's assessment of hospital expansion, HealthCo improvement and the proposed demerger, rather than a guaranteed return.

Stock remains below its yearly high

Apollo Hospitals stock was at INR 7,846.50 on the NSE on October 13, 2026, with a 52-week range of INR 6,696.50 to INR 9,070.50 and market capitalization of INR 1.1 trillion. The price was 13.49 percent below the 52-week high, leaving the November board meeting as the next dated corporate milestone.